Non-blinded, Randomized, Single Center, Single Dose, Cross-over Study to Assess the Effect of a High Calorie/High Fat Meal on the Pharmacokinetics of Four 30 mg Nifurtimox Tablets Taken Orally by Adult Male and Female Patients Suffering From Chronic Chagas' Disease
Phase of Trial: Phase I
Latest Information Update: 19 Aug 2016
At a glance
- Drugs Nifurtimox (Primary)
- Indications Chagas disease
- Focus Pharmacokinetics
- Sponsors Bayer
- 16 Aug 2016 Status changed from active, no longer recruiting to completed.
- 16 Jun 2016 Planned End Date changed from 1 May 2016 to 1 Jul 2016.
- 11 Apr 2016 Status changed from recruiting to active, no longer recruiting.